6,845 findings · Hormonal
- HormonalGood
Deletion of the endocannabinoid-synthesizing enzyme NAPE-PLD specifically in adipose tissue causes obesity, glucose intolerance, and insulin resistance in mice, primarily through impaired adipose browning and altered gut microbiota composition.
This research suggests that the health of your fat tissue is not passive. If the enzymes that produce certain signaling lipids (endocannabinoids) in your fat cells are disrupted, it can trigger a cascade leading to obesity and insulin resistance, partly by changing your gut bacteria. While this is a genetic mouse model, it highlights that metabolic health involves complex communication between fat, gut, and brain, not just food intake.
Supports 2015 - HormonalGood
The metabolic phenotype caused by adipose NAPE-PLD deletion is mediated by changes in gut microbiota composition, as evidenced by the partial transfer of the obese and insulin-resistant phenotype to germ-free mice via fecal microbiota transplantation.
Your gut bacteria play a direct role in your body weight and insulin sensitivity. This study shows that the specific mix of bacteria in your gut can transmit metabolic health information to your fat tissue. While this is a mouse study, it suggests that supporting a healthy gut microbiome may be an important part of metabolic health strategies.
Supports 2015 - HormonalGood
Alternative splicing of the p53 gene produces the p44 variant, which accelerates aging phenotypes, cognitive decline, and senescence by hyperactivating the IGF-1 pathway.
Current research focuses on molecular mechanisms; no direct human intervention is recommended based solely on this paper.
Supports 2017 - HormonalGood
Progeria (HGPS) is caused by a splicing mutation in the LMNA gene producing progerin, which sequesters in the nuclear membrane and reduces SIRT1 activity, modeling vascular aging.
Understanding progeria mechanisms aids research into normal vascular aging.
Supports 2017 - HormonalGood
Androstenedione supplements do not produce anabolic effects or strength improvements in eugonadal men, regardless of age or training status.
Do not rely on androstenedione supplements to build muscle. Studies show that even at 300mg daily combined with training, it does not increase strength more than placebo in either young or older men. The conversion to testosterone is too low to be effective.
Refutes 2002